News
A safety analysis of mRNA vaccination in a phase 1, randomized, open-label clinical trial evaluated the safety and ...
Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification ...
Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...
Explore Rash on Chest Pictures, Causes, Symptoms, Remedies and Treatment to identify your skin condition and find effective ...
21hon MSN
Actress Divyanka Tripathi says she is experiencing massive bouts of itching and rashes during her recovery period from dengue ...
11d
MedPage Today on MSNFDA Approves New Option for Chronic HivesThe FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new targeted drug for the inflammatory skin disease in over a decade, drugmakers ...
People are not born allergic to things, but they can be born with a genetic tendency to become allergic to things to which ...
A urticaria rash can either be a nonimmune response to ... antihistamines or topical corticosteroids for more severe or painful reactions. People with immunological urticaria should note how ...
Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...
The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.
The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU ... 11.27 Safety results across trials showed injection site reactions to be the most common adverse event with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results